You are here

infigratinib

BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results

Investors Business Daily

Tue, 06/4/24 - 11:42 am

BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study

Investors Business Daily

Mon, 03/6/23 - 11:09 am

BridgeBio keeps FDA approval spree rolling, this time with nod for targeted bile duct cancer med

Fierce Pharma

Tue, 06/1/21 - 12:07 pm

bile duct cancer

Cancer drug to treat dwarfism? Abandoned Novartis asset snagged by BridgeBio’s QED Therapeutics

Endpoints

Wed, 01/31/18 - 09:20 am